Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/SPAGO-NANOMEDICAL-AB-120379773/news/Spago-Nanomedical-erreicht-die-nachste-Dosisstufe-in-der-Phase-I-IIa-Studie-Tumorad-01-45712061/?utm_source=whatsapp&utm_medium=social&utm_campaign=share